Standout Papers

Pharmacological Management of Obesity: An Endocrine Society Clinical Pr... 2011 2026 2016 2021 816
  1. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline (2015)
    Caroline M. Apovian, Louis J. Aronne et al. The Journal of Clinical Endocrinology & Metabolism
  2. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease (2011)
    Naoki Kumashiro, Derek M. Erion et al. Proceedings of the National Academy of Sciences
  3. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) (2013)
    Caroline M. Apovian, Louis J. Aronne et al. Obesity

Immediate Impact

1 by Nobel laureates 17 from Science/Nature 82 standout
Sub-graph 1 of 17

Citing Papers

Medications for Obesity
2024 Standout
Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice
2023 Standout
13 intermediate papers

Works of Christopher D. Still being referenced

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
2018
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes
2009
and 7 more

Author Peers

Author Last Decade Papers Cites
Christopher D. Still 2656 2431 1244 1618 160 6.6k
Hermann Toplak 1658 2924 858 1569 125 7.0k
Luca Busetto 3904 4422 1288 1618 177 9.7k
Volkan Yumuk 1837 2895 900 1312 76 6.5k
Bernhard Ludvik 2951 2829 1402 3191 174 8.4k
Dror Dicker 1396 1700 936 1418 120 4.9k
John P. Bantle 3173 3219 775 3274 75 6.9k
Jøran Hjelmesæth 2585 1610 510 1258 174 5.8k
Antonio E. Pontiroli 2290 1551 669 2236 214 5.7k
Alfredo Halpern 1525 2022 579 2206 131 5.3k
Adrian Vella 3662 2383 1119 3967 209 8.3k

All Works

Loading papers...

Rankless by CCL
2026